CAUTION: Investigational device. Limited by United States law to investigational use. The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ...
FLAGSTAFF, Ariz., March 11, 2021 /CNW/ -- W. L. Gore & Associates (Gore), today announced that Gore REDUCE Study long-term follow-up results were published in the March 2021 issue of The New England ...
CAUTION: Investigational device. Limited by United States law to investigational use. The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent foramen ovale (PFO) ...
W.L. Gore & Associates (Gore) has launched a multicenter, prospective, randomized placebo- and sham-controlled investigational study that will evaluate the safety and efficacy of transcatheter closure ...
(MENAFN- GlobeNewsWire - Nasdaq) The PFO closure device market is driven by a shift to minimally invasive solutions and patient-centric care. Opportunities lie in transcatheter methods, bioresorbable ...
Patent foramen ovale (PFO) closure in conjunction with optimal medical therapy can reduce both the number of migraine days and the frequency of attacks compared with medicine alone, according to a new ...
FLAGSTAFF, Ariz. and MIAMI. — W. L. Gore & Associates (Gore) today responded to initial results reported in St. Jude Medical, Inc.’s RESPECT clinical trial. The RESPECT study investigated whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback